MoU Between NIIF and Rusnano OJSC of Russia
04 February 2016
To Set-Up The Russia-India High Technology Private Equity Fund for Joint Implementation of Investments into Projects in India. National Investment and Infrastructure Fund (NIIF) has signed a Memorandum of Understanding (MoU) with RUSNANO OJSC of Russia
Emerging trends in microbiological diagnostics: an introduction to rapid microbiological methods
04 February 2016
Just like any other scientific study, the continuous study of microbiology has been coincidental with the emergence of new ideas, methods and technologies.
How Testing Workers' Genes Could Make Office Wellness Programs Work
04 February 2016
Tell people they have a genetic condition and it might get them to stick with weight-loss regimens. Aprillia Jeffries is a model success story for her company's efforts at improving the health of its staff. Jeffries, who works at Aetna, has lost 50 pounds and dropped eight dress sizes in the last two and a half years through a program at Aetna run by Newtopia, a company that provides wellness services.
Cleveland BioLabs Announces Start of Colorectal Cancer Study of Entolimod in Russian Federation
03 February 2016
Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the initiation of a Phase 2, single-blind, randomized, placebo-controlled clinical study of the safety and tolerability of entolimod as a neo-adjuvant therapy in treatment-naïve patients with primary colorectal cancer who are recommended for surgery. Up to 32 patients are expected to be enrolled in the study, which is being conducted at four leading oncology centers in the Russian Federation. The study is supported by a development contract with the Russian Federation Ministry of Industry and Trade.
Siberian medical researchers named world’s best in clinical trials for diabetes
03 February 2016
The Tomsk-based Siberian State Medical University has been officially declared the world’s best center for clinical trials to test new drug candidates for type 2 diabetes, portal Science and Technologies RF reported . The university received a gold certificate at the most recent Global Study Symposium of international researchers in Rome.
More link think? OPDP lists social media links as guidance item for 2016
02 February 2016
The FDA's promotional police plan to address social media links for pharma again this year. Maybe. That is, the issue is on the agency's annual agenda of "new and revised draft guidances CDER is planning to publish during calendar year 2016." And the item specifically states that the FDA plans to look at the "use of links to third-party sites," according to the guidance documen
Russia ranked one of world's most innovative economies
02 February 2016
In spite of current economic challenges, Bloomberg ranks Russia one of the world’s most innovative economies.
Russia rose two spots to overall #12 in this year’s Bloomberg Innovation Index , which ranks the innovative capacity of the world's top-50 innovative countries.
France triples size of biotech investment fund following industry criticism
02 February 2016
The French government is planning to triple the size of its biotech investment fund after the industry balked at the initial proposal. Officials now intend to hive off €340 million ($380 million) for the fund, more than three times the amount earmarked when they first floated the idea last year.
Biomarker Discovery Gets a Fix on Cancer
01 February 2016
ust as signposts provide information, direction, and guidance, so too cancer biomarkers can better reveal the complex, dynamic, and heterogeneous landscape of malignancies. Such information is critical for creating better cancer diagnostics, prognostics, and therapeutics, but the journey to find just the right biomarker is often a long and winding road.
Despite capital markets meltdown money flows into biopharma
01 February 2016
With the 34th annual J.P. Morgan Healthcare conference now in our rearview mirror we can reflect on the lessons learned from that pivotal event that traditionally helps set the agenda for the industry. There is no doubt that biopharma executives attending the meeting generally believe that 2016 will be vibrant – a sentiment echoed by many of the presenting companies who indicated they were looking forward to an "exciting" year ahead. Investors seem to be of the same mind, with more than $2 billion flowing to public and private companies so far in January despite the unfavorable capital markets.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024
Microbial burden assessment of solid pharmaceutical products
22 April 2024
Seasonal variation of microbial contamination in pharmaceutical cleanrooms
22 April 2024